These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Outcomes following implantation of mechanical circulatory support in adults with congenital heart disease: An analysis of the Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS). VanderPluym CJ; Cedars A; Eghtesady P; Maxwell BG; Gelow JM; Burchill LJ; Maltais S; Koehl DA; Cantor RS; Blume ED J Heart Lung Transplant; 2018 Jan; 37(1):89-99. PubMed ID: 28365175 [TBL] [Abstract][Full Text] [Related]
6. Is Implantation of a Left Ventricular Assist Device in Patients With Critical or Impending Cardiogenic Shock an Absolute Contraindication? Looking Back at Our Past Experience Trying to Identify Contraindicative Risk Factors. Dell'Aquila AM; Schneider SR; Risso P; Welp H; Glockner DG; Alles S; Sindermann JR; Scherer M Artif Organs; 2015 Dec; 39(12):998-1004. PubMed ID: 26011007 [TBL] [Abstract][Full Text] [Related]
7. Ventricular Assist Device in Acute Myocardial Infarction. Acharya D; Loyaga-Rendon RY; Pamboukian SV; Tallaj JA; Holman WL; Cantor RS; Naftel DC; Kirklin JK J Am Coll Cardiol; 2016 Apr; 67(16):1871-80. PubMed ID: 27102502 [TBL] [Abstract][Full Text] [Related]
8. Clinical Outcomes After Left Ventricular Assist Device Implantation in Older Adults: An INTERMACS Analysis. Caraballo C; DeFilippis EM; Nakagawa S; Ravindra NG; Miller PE; Mezzacappa C; McCullough M; Gruen J; Levin A; Reinhardt S; Mullan C; Ali A; Maurer MS; Desai NR; Ahmad T; Topkara VK JACC Heart Fail; 2019 Dec; 7(12):1069-1078. PubMed ID: 31779930 [TBL] [Abstract][Full Text] [Related]
9. Results of the post-U.S. Food and Drug Administration-approval study with a continuous flow left ventricular assist device as a bridge to heart transplantation: a prospective study using the INTERMACS (Interagency Registry for Mechanically Assisted Circulatory Support). Starling RC; Naka Y; Boyle AJ; Gonzalez-Stawinski G; John R; Jorde U; Russell SD; Conte JV; Aaronson KD; McGee EC; Cotts WG; DeNofrio D; Pham DT; Farrar DJ; Pagani FD J Am Coll Cardiol; 2011 May; 57(19):1890-8. PubMed ID: 21545946 [TBL] [Abstract][Full Text] [Related]
10. INTERMACS Analysis of Stroke During Support With Continuous-Flow Left Ventricular Assist Devices: Risk Factors and Outcomes. Acharya D; Loyaga-Rendon R; Morgan CJ; Sands KA; Pamboukian SV; Rajapreyar I; Holman WL; Kirklin JK; Tallaj JA JACC Heart Fail; 2017 Oct; 5(10):703-711. PubMed ID: 28958345 [TBL] [Abstract][Full Text] [Related]
11. The Society of Thoracic Surgeons Intermacs Database Annual Report: Evolving Indications, Outcomes, and Scientific Partnerships. Kormos RL; Cowger J; Pagani FD; Teuteberg JJ; Goldstein DJ; Jacobs JP; Higgins RS; Stevenson LW; Stehlik J; Atluri P; Grady KL; Kirklin JK Ann Thorac Surg; 2019 Feb; 107(2):341-353. PubMed ID: 30691584 [TBL] [Abstract][Full Text] [Related]
12. Results of the destination therapy post-food and drug administration approval study with a continuous flow left ventricular assist device: a prospective study using the INTERMACS registry (Interagency Registry for Mechanically Assisted Circulatory Support). Jorde UP; Kushwaha SS; Tatooles AJ; Naka Y; Bhat G; Long JW; Horstmanshof DA; Kormos RL; Teuteberg JJ; Slaughter MS; Birks EJ; Farrar DJ; Park SJ; J Am Coll Cardiol; 2014 May; 63(17):1751-7. PubMed ID: 24613333 [TBL] [Abstract][Full Text] [Related]
13. The role of implantable cardioverter-defibrillators in patients with continuous flow left ventricular assist devices. Enriquez AD; Calenda B; Miller MA; Anyanwu AC; Pinney SP Circ Arrhythm Electrophysiol; 2013 Aug; 6(4):668-74. PubMed ID: 23873139 [TBL] [Abstract][Full Text] [Related]
14. Outcomes After Continuous-Flow Left Ventricular Assist Device Implantation as Destination Therapy at Transplant Versus Nontransplant Centers. Brinkley DM; DeNofrio D; Ruthazer R; Vest AR; Kapur NK; Couper GS; Kiernan MS Circ Heart Fail; 2018 Mar; 11(3):e004384. PubMed ID: 29540471 [TBL] [Abstract][Full Text] [Related]
15. Novel percutaneous dual-lumen cannula-based right ventricular assist device provides effective support for refractory right ventricular failure after left ventricular assist device implantation. Salna M; Garan AR; Kirtane AJ; Karmpaliotis D; Green P; Takayama H; Sanchez J; Kurlansky P; Yuzefpolskaya M; Colombo PC; Naka Y; Takeda K Interact Cardiovasc Thorac Surg; 2020 Apr; 30(4):499-506. PubMed ID: 31986207 [TBL] [Abstract][Full Text] [Related]
16. Interagency Registry for Mechanically Assisted Circulatory Support (INTERMACS) analysis of pump thrombosis in the HeartMate II left ventricular assist device. Kirklin JK; Naftel DC; Kormos RL; Pagani FD; Myers SL; Stevenson LW; Acker MA; Goldstein DL; Silvestry SC; Milano CA; Baldwin JT; Pinney S; Eduardo Rame J; Miller MA J Heart Lung Transplant; 2014 Jan; 33(1):12-22. PubMed ID: 24418730 [TBL] [Abstract][Full Text] [Related]
17. Early Right Ventricular Assist Device Use in Patients Undergoing Continuous-Flow Left Ventricular Assist Device Implantation: Incidence and Risk Factors From the Interagency Registry for Mechanically Assisted Circulatory Support. Kiernan MS; Grandin EW; Brinkley M; Kapur NK; Pham DT; Ruthazer R; Rame JE; Atluri P; Birati EY; Oliveira GH; Pagani FD; Kirklin JK; Naftel D; Kormos RL; Teuteberg JJ; DeNofrio D Circ Heart Fail; 2017 Oct; 10(10):. PubMed ID: 29021348 [TBL] [Abstract][Full Text] [Related]